etnangien derivatives (HZI)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameetnangien derivatives (HZI)
Drug Alias Nameetnangienetnangien methyl ester
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHelmholtz Zentrum fur Infektionsforschung GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelmholtz Zentrum fur Infektionsforschung GmbHAscenion
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A